Skip to main content
Log in

Dermal Microdialysis Sampling in Vivo

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Microdialysis sampling of the dermis in vivo was accomplished using a linear microdialysis probe. In contrast to previous studies using a commercial cannula-style microdialysis probe, the linear probe had no effect on the flux of drug through the skin in vitro. The extent of tissue damage in vivo due to probe implantation was evaluated by histological examination and microdialysis delivery studies. Tissue damage due to implantation of the linear probe was minimal with no bleeding or edema observed. Infiltration of lymphocytes into the tissue was observed beginning 6 hours after probe implantation with scar tissue beginning to form after approximately 32 hours. The infiltration of lymphocytes had no effect on the behavior of implanted microdialysis probes. Delivery of 5-fluorouracil was between 20 and 25% for six different probes implanted in six different animals demonstrating good probe-to-probe and implantation-to-implantation reproducibility. Constant delivery was maintained for at least 24 hours in all cases indicating that experiments of at least 24 hour duration are feasible. The dermal concentration of topically applied 5-FU cream, Efudex®, was continuously monitored by an implanted microdialysis probe demonstrating the feasibility of this technique as for monitoring skin drug levels in vivo. The dermal concentration of 5-FU following topical application was approximately 40-fold higher for in vitro excised skin than for in vivo intact skin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. S. Chong and H.-L. Fung. Transdermal Drug Delivery Systems: Pharmacokinetics, Clinical Efficacy, and Tolerance Development, in “Transdermal Drug Delivery” (J. Hadgraft and R.H. Guy, eds.) Marcel Dekker: New York, 1989, pg. 135–153.

    Google Scholar 

  2. R.H. Guy and J. Hadgraft. Transdermal Drug Delivery — A Simplified Pharmacokinetic Approach. Int. J. Pharm. 24:267–274(1985).

    Google Scholar 

  3. R.H. Guy, J. Hadgraft and D.A.W. Bucks. Transdermal Drug Delivery and Cutaneous Metabolism. Xenobiotica 17:325–343(1987).

    Google Scholar 

  4. J.W. Stone, J.M. Andrews, J.P. Ashby, D. Griggs, and R. Wise. Pharmacokinetics and Tissue Penetration of Orally Administered Lomefloxacin. Antimicrob. Agents Chemother. 32:1508–1510(1988).

    Google Scholar 

  5. R.L. Bronaugh and H.I. Maibach. In Vitro Models for Human Percutaneous Adsorption, in “Models in Dermatology” (H.I. Maibach and N.J. Lowe, eds.) Karger: Basel, 1985, p. 178–188.

    Google Scholar 

  6. Y.W. Chien. Development of Transdermal Drug Delivery Systems. Drug Dev. Ind. Pharm. 13:589–651(1987).

    Google Scholar 

  7. R.H. Guy, J. Hadgraft, R.S. Hinz, K.V. Roskos and D.A.W. Bucks, in “Transdermal Controlled Systemic Medications” (Y.W. Chien, ed.), Marcel Dekker: New York, 1987, pg. 205.

    Google Scholar 

  8. J. M. Ault, C. E. Lunte, N. M. Meltzer, and C. M. Riley. Microdialysis sampling for the investigation of dermal drug transport. Pharm. Res. 9:1256–1261 (1992).

    Google Scholar 

  9. U. Ungerstedt and C. Pycock. Functional correlates of dopamine neurotransmission. Bull. Schweiz. Akad. Med. Wiss. 1278:1–13 (1974).

    Google Scholar 

  10. N. W. Bunnett, M. Mogard, M. S. Orloff, H. J. Corbet, J. R. Reeve, Jr., and J. H. Walsh. Catabolism of neurotensin in interstitial fluid of the rat stomach. Am. J. Physiol. 246:675–682 (1984).

    Google Scholar 

  11. U. Tossman, T. Wieloch, and U. Ungerstedt. Gama-amino-butyric acid and taurine release in the striatum of the rat during hypoglycemic coma studied by microdialysis. Neurosci. Lett. 62:231–235 (1985).

    Google Scholar 

  12. H. Jarry, E. M. Duher, and W. Wuttke. Adrenal release of catecholamine and metenkephalin before and after stress as measured by a novel in vivo dialysis method on the rat. Neurosci. Lett. 60:273–278 (1985).

    Google Scholar 

  13. A. Imperato and G. Di Chiara. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine metabolites. J. Neurosci. Lett. 4:966–977 (1984).

    Google Scholar 

  14. K. Matsuyama, M. Nakashima, Y. Nakaboh, M. Ichikawa, T. Yano, and S. Satoh. Application of in vivo microdialysis to transdermal absorption of methotrexate in rats. Pharm. Res. 11:684–686(1994).

    Google Scholar 

  15. E. V. Hagstrom-Toft, P. Arner, U. Johansson, L. S. Eriksson, U. Ungerstedt and J. Bolinder. Effect of insulin on human adipose tissue metabolism in situ. Interactions with beta-adrenoceptors. Diabetologia 35:664–670 (1992).

    Google Scholar 

  16. D. Scheller and J. Kolb. The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialyzate samples. J. Neurosci. Methods 40:31–38 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ault, J.M., Riley, C.M., Meltzer, N.M. et al. Dermal Microdialysis Sampling in Vivo . Pharm Res 11, 1631–1639 (1994). https://doi.org/10.1023/A:1018922123774

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018922123774

Navigation